These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 36674602)

  • 1. Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
    Ciccarelli G; Conte S; Cimmino G; Maiorano P; Morrione A; Giordano A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis.
    Salnikova D; Orekhova V; Grechko A; Starodubova A; Bezsonov E; Popkova T; Orekhov A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mitochondrial dysfunction on cellular function: Role in atherosclerosis.
    Xu M; Wang W; Cheng J; Qu H; Xu M; Wang L
    Biomed Pharmacother; 2024 May; 174():116587. PubMed ID: 38636397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness.
    Yu EPK; Reinhold J; Yu H; Starks L; Uryga AK; Foote K; Finigan A; Figg N; Pung YF; Logan A; Murphy MP; Bennett M
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2322-2332. PubMed ID: 28970293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies.
    Shemiakova T; Ivanova E; Wu WK; Kirichenko TV; Starodubova AV; Orekhov AN
    Front Cardiovasc Med; 2021; 8():660473. PubMed ID: 34017868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mitochondria in cardiovascular diseases related to atherosclerosis.
    Glanz VY; Sobenin IA; Grechko AV; Yet SF; Orekhov AN
    Front Biosci (Elite Ed); 2020 Jan; 12(1):102-112. PubMed ID: 31585872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.
    Yu E; Calvert PA; Mercer JR; Harrison J; Baker L; Figg NL; Kumar S; Wang JC; Hurst LA; Obaid DR; Logan A; West NE; Clarke MC; Vidal-Puig A; Murphy MP; Bennett MR
    Circulation; 2013 Aug; 128(7):702-12. PubMed ID: 23841983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.
    Orekhov AN; Poznyak AV; Sobenin IA; Nikifirov NN; Ivanova EA
    Curr Neuropharmacol; 2020; 18(11):1064-1075. PubMed ID: 31744449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial reactive oxygen species and risk of atherosclerosis.
    Hulsmans M; Van Dooren E; Holvoet P
    Curr Atheroscler Rep; 2012 Jun; 14(3):264-76. PubMed ID: 22350585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction.
    Mikhed Y; Daiber A; Steven S
    Int J Mol Sci; 2015 Jul; 16(7):15918-53. PubMed ID: 26184181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications.
    Sobenin IA; Chistiakov DA; Bobryshev YV; Postnov AY; Orekhov AN
    Curr Pharm Des; 2013; 19(33):5942-53. PubMed ID: 23438955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA damage and atherosclerosis.
    Yu EP; Bennett MR
    Trends Endocrinol Metab; 2014 Sep; 25(9):481-7. PubMed ID: 25034130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.
    Puddu P; Puddu GM; Cravero E; De Pascalis S; Muscari A
    J Biomed Sci; 2009 Dec; 16(1):112. PubMed ID: 20003216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis.
    Puddu P; Puddu GM; Galletti L; Cravero E; Muscari A
    Cardiology; 2005; 103(3):137-41. PubMed ID: 15665536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging.
    Wang CH; Wu SB; Wu YT; Wei YH
    Exp Biol Med (Maywood); 2013 May; 238(5):450-60. PubMed ID: 23856898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorating Endothelial Mitochondrial Dysfunction Restores Coronary Function via Transient Receptor Potential Vanilloid 1-Mediated Protein Kinase A/Uncoupling Protein 2 Pathway.
    Xiong S; Wang P; Ma L; Gao P; Gong L; Li L; Li Q; Sun F; Zhou X; He H; Chen J; Yan Z; Liu D; Zhu Z
    Hypertension; 2016 Feb; 67(2):451-60. PubMed ID: 26667415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in atherosclerosis.
    Madamanchi NR; Runge MS
    Circ Res; 2007 Mar; 100(4):460-73. PubMed ID: 17332437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Dysfunction in Atherosclerosis.
    Peng W; Cai G; Xia Y; Chen J; Wu P; Wang Z; Li G; Wei D
    DNA Cell Biol; 2019 Jul; 38(7):597-606. PubMed ID: 31095428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alterations of mitochondrial DNA in coronary heart disease.
    Hu H; Lin Y; Xu X; Lin S; Chen X; Wang S
    Exp Mol Pathol; 2020 Jun; 114():104412. PubMed ID: 32113905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal programming of atherosclerosis: possible role of the mitochondria.
    Leduc L; Levy E; Bouity-Voubou M; Delvin E
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):127-30. PubMed ID: 20053495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.